{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:00:26Z","timestamp":1790841626333,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.tcm.2022.02.008","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T03:59:57Z","timestamp":1645502397000},"page":"249-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0255-4088","authenticated-orcid":false,"given":"Toshiaki","family":"Iba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrold H.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.tcm.2022.02.008_bib0001","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","article-title":"Coagulation abnormalities and thrombosis in patients with COVID-19","volume":"7","author":"Levi","year":"2020","journal-title":"Lancet Haematol"},{"issue":"22","key":"10.1016\/j.tcm.2022.02.008_bib0002","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.tcm.2022.02.008_bib0003","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.tcm.2022.02.008_bib0004","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jama.2021.15072","article-title":"Surveillance for adverse events after COVID-19 mRNA vaccination","volume":"326","author":"Klein","year":"2021","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.tcm.2022.02.008_bib0005","first-page":"00096","article-title":"The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia","volume":"S1050-1738","author":"Iba","year":"2021","journal-title":"Trends Cardiovasc Med"},{"issue":"18","key":"10.1016\/j.tcm.2022.02.008_bib0006","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.jacc.2020.08.070","article-title":"Registry of arterial and venous thromboembolic complications in patients with COVID-19","volume":"76","author":"Piazza","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.tcm.2022.02.008_bib0007","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00011-020-01401-6","article-title":"The coagulopathy, endotheliopathy, and vasculitis of COVID-19","volume":"69","author":"Iba","year":"2020","journal-title":"Inflamm Res"},{"issue":"9","key":"10.1016\/j.tcm.2022.02.008_bib0008","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/jth.14975","article-title":"Coagulopathy in COVID-19","volume":"18","author":"Iba","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"16","key":"10.1016\/j.tcm.2022.02.008_bib0009","doi-asserted-by":"crossref","first-page":"7448","DOI":"10.7150\/thno.48076","article-title":"SARS-CoV-2 pandemic and research gaps: understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy","volume":"10","author":"Datta","year":"2020","journal-title":"Theranostics"},{"issue":"21","key":"10.1016\/j.tcm.2022.02.008_bib0010","first-page":"02270","article-title":"SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfate","volume":"S0141-8130","author":"Zheng","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.tcm.2022.02.008_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101061","article-title":"Cerebral venous thrombosis and portal vein thrombosis: a retrospective cohort study of 537,913 COVID-19 cases","volume":"39","author":"Taquet","year":"2021","journal-title":"eClinicalMedicine"},{"issue":"1","key":"10.1016\/j.tcm.2022.02.008_bib0012","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13054-020-03077-0","article-title":"The unique characteristics of COVID-19 coagulopathy","volume":"24","author":"Iba","year":"2020","journal-title":"Crit Care"},{"issue":"22","key":"10.1016\/j.tcm.2022.02.008_bib0013","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.tcm.2022.02.008_bib0014","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jama.2021.9889","article-title":"Frequency of thrombocytopenia and platelet factor 4\/heparin antibodies in patients with cerebral venous sinus thrombosis prior to the COVID-19 pandemic","volume":"326","author":"S\u00e1nchez van Kammen","year":"2021","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.tcm.2022.02.008_bib0015","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1111\/ene.15029","article-title":"Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European medicines agency","volume":"28","author":"Krzywicka","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.tcm.2022.02.008_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117607","article-title":"Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review","volume":"428","author":"Sharifian-Dorche","year":"2021","journal-title":"J Neurol Sci"},{"issue":"8","key":"10.1016\/j.tcm.2022.02.008_bib0017","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.3324\/haematol.2021.279000","article-title":"Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia","volume":"106","author":"Althaus","year":"2021","journal-title":"Haematologica"},{"issue":"7873","key":"10.1016\/j.tcm.2022.02.008_bib0018","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.tcm.2022.02.008_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102662","article-title":"Mechanisms of immunothrombosis in vaccine-induced thrombotic thrombocytopenia (VITT) compared to natural SARS-CoV-2 infection","volume":"121","author":"McGonagle","year":"2021","journal-title":"J Autoimmun"},{"issue":"22","key":"10.1016\/j.tcm.2022.02.008_bib0020","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1182\/blood.2021013231","article-title":"Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia","volume":"138","author":"Greinacher","year":"2021","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.tcm.2022.02.008_bib0021","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2022.02.008_bib0022","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMe2106315","article-title":"SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia","volume":"384","author":"Cines","year":"2021","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.tcm.2022.02.008_bib0023","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1182\/blood.2021012938","article-title":"Antiplatelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein","volume":"138","author":"Greinacher","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.tcm.2022.02.008_bib0024","doi-asserted-by":"crossref","first-page":"n1931","DOI":"10.1136\/bmj.n1931","article-title":"Risk of thrombocytopenia and thromboembolism after COVID-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study","volume":"374","author":"Hippisley-Cox","year":"2021","journal-title":"BMJ"},{"issue":"43","key":"10.1016\/j.tcm.2022.02.008_bib0025","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1016\/j.vaccine.2017.08.086","article-title":"Risk of venous thromboembolism following influenza vaccination in adults aged 50 years and older in the vaccine safety datalink","volume":"35","author":"Vickers","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.tcm.2022.02.008_bib0026","unstructured":"Burn E, Roel E, Pistillo A, Fernandez-Bertol\u00ed S, Arag\u00f3n M, Carlen Reyes C, et\u00a0al. Thromboembolic events and thrombosis with thrombocytopenia after COVID-19 infection and vaccination in Catalonia, Spain. https:\/\/www.medrxiv.org\/content\/10.1101\/2021.07.29.21261348v1."},{"key":"10.1016\/j.tcm.2022.02.008_bib0027","unstructured":"Burn E, Li X, Delmestri A, Jones N, Duarte-Salles T, Reyes C, et\u00a0al. Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2: a population-based cohort analysis. doi:10.1101\/2021.07.29.21261348v1"},{"issue":"12","key":"10.1016\/j.tcm.2022.02.008_bib0028","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 mRNA COVID-19 vaccine in a nationwide setting","volume":"385","author":"Barda","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.tcm.2022.02.008_bib0029","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood.2021012217","article-title":"Frequency of positive anti-PF4\/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2","volume":"138","author":"Thiele","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.tcm.2022.02.008_bib0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bbrc.2003.09.171","article-title":"Platelet factor 4 neutralizes heparan sulfate-enhanced antithrombin inactivation of factor Xa by preventing interaction(s) of enzyme with polysaccharide","volume":"311","author":"Fiore","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.tcm.2022.02.008_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001109","article-title":"COVID-19 induces a hyperactive phenotype in circulating platelets","volume":"19","author":"Comer","year":"2021","journal-title":"PLoS Biol"},{"issue":"6","key":"10.1016\/j.tcm.2022.02.008_bib0032","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1213\/ANE.0b013e3182662e1a","article-title":"A case series of recombinant platelet factor 4 for heparin reversal after cardiopulmonary bypass","volume":"115","author":"Demma","year":"2012","journal-title":"Anesth Analg"},{"issue":"6","key":"10.1016\/j.tcm.2022.02.008_bib0033","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/jth.13955","article-title":"Platelets kill bacteria by bridging innate and adaptive immunity via platelet factor 4 and Fc\u03b3RIIA","volume":"16","author":"Palankar","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"15","key":"10.1016\/j.tcm.2022.02.008_bib0034","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMcibr2111445","article-title":"In gratitude for mRNA vaccines","volume":"385","author":"Stuart","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2022.02.008_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.728513","article-title":"Pathogenic mechanisms of vaccine-induced immune thrombotic thrombocytopenia in people receiving anti-COVID-19 adenoviral-based vaccines: a proposal","volume":"12","author":"Azzarone","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.tcm.2022.02.008_bib0036","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1111\/bjh.16950","article-title":"Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID-19","volume":"190","author":"Maquet","year":"2020","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.tcm.2022.02.008_bib0037","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00296-020-04636-y","article-title":"Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic","volume":"41","author":"Soy","year":"2021","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.tcm.2022.02.008_bib0038","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/jth.15283","article-title":"Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia","volume":"19","author":"Nazy","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tcm.2022.02.008_bib0039","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.thromres.2018.09.060","article-title":"Anti-PF4\/heparin antibodies are increased in hospitalized patients with bacterial sepsis","volume":"171","author":"Maharaj","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.tcm.2022.02.008_bib0040","first-page":"1","article-title":"Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy","author":"Cacciola","year":"2021","journal-title":"J Thromb Thrombolysis"},{"issue":"7","key":"10.1016\/j.tcm.2022.02.008_bib0041","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1055\/a-1333-4688","article-title":"Contrast between prevalence of HIT antibodies and confirmed HIT in hospitalized COVID-19 patients: a prospective study with clinical implications","volume":"121","author":"Delrue","year":"2021","journal-title":"Thromb Haemost"},{"issue":"05","key":"10.1016\/j.tcm.2022.02.008_bib0042","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/rth2.12390","article-title":"Heparin-induced thrombocytopenia with thrombosis in COVID-19 adult respiratory distress syndrome","volume":"4","author":"Riker","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.tcm.2022.02.008_bib0043","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.25935","article-title":"Heparin induced thrombocytopenia antibodies in COVID-19","author":"Patell","year":"2020","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.tcm.2022.02.008_bib0044","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00134-004-2334-1","article-title":"Thrombosis and hemorrhage in heparin-induced thrombocytopenia in seriously ill patients","volume":"30","author":"Wester","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.tcm.2022.02.008_bib0045","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2112974","article-title":"Vaccine-induced thrombocytopenia with severe headache","author":"Salih","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.tcm.2022.02.008_bib0046","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjh.17645","article-title":"Exacerbation of immune thrombocytopenia following COVID-19 vaccination","volume":"195","author":"Kuter","year":"2021","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.tcm.2022.02.008_bib0047","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/ajh.26132","article-title":"Thrombocytopenia following pfizer and moderna SARS-CoV-2 vaccination","volume":"96","author":"Lee","year":"2021","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.tcm.2022.02.008_bib0048","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.vaccine.2010.11.051","article-title":"Thrombocytopenia after vaccination: case reports to the US vaccine adverse event reporting system, 1990-2008","volume":"29","author":"Woo","year":"2011","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.tcm.2022.02.008_bib0049","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.tcm.2022.02.008_bib0050","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1358863X19898253","article-title":"Heparin-induced thrombocytopenia (HIT): review of incidence, diagnosis, and management","volume":"25","author":"Hogan","year":"2020","journal-title":"Vasc Med"},{"key":"10.1016\/j.tcm.2022.02.008_bib0051","article-title":"Recognizing vaccine-induced immune thrombotic thrombocytopenia","author":"Iba","year":"2021","journal-title":"Crit Care Med"},{"issue":"10","key":"10.1016\/j.tcm.2022.02.008_bib0052","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.7326\/L21-0244","article-title":"Thrombosis with thrombocytopenia after the messenger RNA-1273 vaccine","volume":"174","author":"Sangli","year":"2021","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.tcm.2022.02.008_bib0053","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/jth.13813","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"15","author":"Greinacher","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"12","key":"10.1016\/j.tcm.2022.02.008_bib0054","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.41425","article-title":"Antiphospholipid antibodies in critically Ill patients with COVID-19","volume":"72","author":"Xiao","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.tcm.2022.02.008_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.687534","article-title":"Antiphospholipid antibodies and infection: non nova sed nove","volume":"12","author":"Sciascia","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.tcm.2022.02.008_bib0056","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cytogfr.2021.05.001","article-title":"Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: the straw that breaks the camel's back?","volume":"60","author":"Talotta","year":"2021","journal-title":"Cytokine Growth Factor Rev"},{"issue":"21","key":"10.1016\/j.tcm.2022.02.008_bib0057","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.tcm.2022.02.008_bib0058","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-238026","article-title":"COVID-19 presenting as thrombotic thrombocytopenic purpura (TTP)","volume":"13","author":"Altowyan","year":"2020","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.tcm.2022.02.008_bib0059","article-title":"The utility of a fast turnaround ADAMTS13 activity in the diagnosis and exclusion of thrombotic thrombocytopenic purpura","author":"Thomas","year":"2018","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.tcm.2022.02.008_bib0060","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/ajh.26241","article-title":"Laboratory testing for ADAMTS13: utility for TTP diagnosis\/exclusion and beyond","volume":"96","author":"Favaloro","year":"2021","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.tcm.2022.02.008_bib0061","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-246049","article-title":"Thrombotic thrombocytopenic purpura after ChAdOx1 nCoV-19 vaccine","volume":"14","author":"Lee","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"9","key":"10.1016\/j.tcm.2022.02.008_bib0062","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1111\/jth.15420","article-title":"Acquired thrombotic thrombocytopenic purpura: a rare disease associated with BNT162b2 vaccine","volume":"19","author":"Maayan","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.tcm.2022.02.008_bib0063","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12185-021-03190-y","article-title":"Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine","volume":"114","author":"Waqar","year":"2021","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.tcm.2022.02.008_bib0064","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/tmrv.2003.50004","article-title":"Cellular immune mechanisms in autoimmune thrombocytopenic purpura: an update","volume":"17","author":"Coopamah","year":"2003","journal-title":"Transfus Med Rev"},{"issue":"11","key":"10.1016\/j.tcm.2022.02.008_bib0065","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1007\/s42399-020-00521-8","article-title":"Immune thrombocytopenia secondary to COVID-19: a systematic review","volume":"2","author":"Bhattacharjee","year":"2020","journal-title":"SN Compr Clin Med"},{"issue":"25","key":"10.1016\/j.tcm.2022.02.008_bib0066","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1016\/j.vaccine.2021.04.054","article-title":"Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the vaccine adverse event reporting system (VAERS)","volume":"39","author":"Welsh","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.tcm.2022.02.008_bib0067","article-title":"ChAdOx1 nCoV-19 vaccine-associated thrombocytopenia: three cases of immune thrombocytopenia after 107\u200a720 doses of ChAdOx1 vaccination in Thailand","author":"Uaprasert","year":"2021","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"10","key":"10.1016\/j.tcm.2022.02.008_bib0068","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1177\/09612033211024355","article-title":"Lupus, vaccinations and COVID-19: what we know now","volume":"30","author":"Mason","year":"2021","journal-title":"Lupus"},{"issue":"11","key":"10.1016\/j.tcm.2022.02.008_bib0069","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11926-021-01046-2","article-title":"The use of COVID-19 vaccines in patients with SLE","volume":"23","author":"Tang","year":"2021","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.tcm.2022.02.008_bib0070","article-title":"Thrombocytopenia after coronavirus disease 2019 vaccination: remember to put the blame on others too","author":"De Bruyne","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.tcm.2022.02.008_bib0071","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1538-7836.2009.03335.x","article-title":"False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus","volume":"7","author":"Pauzner","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tcm.2022.02.008_bib0072","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcmd.2016.10.023","article-title":"Recent advances in diagnostic and therapeutic guidelines for primary and secondary hemophagocytic lymphohistiocytosis","volume":"64","author":"Ramachandra","year":"2017","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.tcm.2022.02.008_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2021.110700","article-title":"Models for SARS-CoV-2 associated thrombocytopenia associated with hemophagocytic histiocytes","volume":"157","author":"Ricke","year":"2021","journal-title":"Med Hypotheses"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105017382200038X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105017382200038X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T05:02:27Z","timestamp":1760936547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105017382200038X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S105017382200038X"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2022.02.008","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2022.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}